Mutations in the Kinase Domain of the HER2/ERBB2 Gene Identified in a Wide Variety of Human Cancers

Overview of attention for article published in The Journal of Molecular Diagnostics, September 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter: 2 X users

patent: 10 patents

Readers on

mendeley: 109 Mendeley

So far, Altmetric has seen 10 patents that reference this research output.

Compounds with anti-tumor activity against cancer cells bearing HER2 exon 19 mutations

Grant US-12714708-B2

United States of America

25 Aug 2026

Compounds with anti-tumor activity against cancer cells bearing HER2 exon 21 insertions

Grant US-12629375-B2

United States of America

19 May 2026

Compounds with antitumor activity against cancer cells with HER2 exon 21 insertions

Grant JP-7700043-B2

Japan

30 Jun 2025

Amino-substituted heteroaryls for treating cancers with EGFR mutations

Grant US-12037346-B2

United States of America

16 Jul 2024

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 6 additional patents.